Redesigning cancer care

doi:10.1136/bmj.324.7330.164

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ education articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

David Kerr, Rhodes professor of therapeutics and clinical pharmacology (David.Kerr@clinpharm.ox.ac.uk)a,
Helen Bevan, director of redesignb,
Ben Gowland, managerb,
Jean Penny, senior fellowb,
Don Berwick, chief executive officerc

^a Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE,
^b National Patients' Access Team, 2A New Walk, Leicester LE1 6TF,
^c Institute for Healthcare Improvement, 375 Longwood Avenue, Boston, MA 02215, USA

Correspondence to: David Kerr

We have known for some time that cancer treatment in the United Kingdom needs to improve. This report looks at an attempt to use the collaborative improvement model to enhance services. We made considerable progress in the first year, and the model is now being applied to other cancers and other medical areas.

Summary points

Patients with cancer in the UK suffer more delays and worse survival than those in many other European states

The national cancer plan has set ambitious targets for improved care

The cancer services collaborative is using improvement methods to reduce delays and improve the service for patients

The nine cancer networks using these methods have cut waiting times and improved patients' experiences of care

Background: the cancer services collaborative

Cancer patients in the UK face long delays before treatment1 and their survival rates compare badly with those in the US and many European countries.2 As a response to this, the Department of Health produced the National Cancer Plan,3 which ranges from prevention to palliative care, and made cancer networks responsible for improving care. As a central part of this strategy, the cancer services collaborative was set up, initially to improve care in specific areas, and then throughout the NHS.

The collaborative involves nine cancer networks, at least one in each English region (see box), covering a population of 14 million, and coordinated by the National Patients' Access Team. This team is part of the NHS's Modernisation Agency, funded by the Department of Health to implement various aspects of the NHS's National Plan. In each network we funded a programme director and a facilitator for each of five tumour types: bowel, breast, lung, prostate, and ovary. We also appointed clinical leads to work with the facilitators, and bought clinical sessions when needed. The networks are autonomous but have to submit …